Lantern Pharma Inc (LTRN)
6.15
+0.71
(+13.05%)
USD |
NASDAQ |
May 03, 15:33
Lantern Pharma Total Liabilities (Quarterly): 2.740M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.740M |
| September 30, 2023 | 2.360M |
| June 30, 2023 | 3.167M |
| March 31, 2023 | 2.934M |
| December 31, 2022 | 2.798M |
| September 30, 2022 | 3.139M |
| June 30, 2022 | 5.304M |
| March 31, 2022 | 3.087M |
| December 31, 2021 | 2.379M |
| Date | Value |
|---|---|
| September 30, 2021 | 1.878M |
| June 30, 2021 | 2.819M |
| March 31, 2021 | 0.773M |
| December 31, 2020 | 0.6608M |
| September 30, 2020 | 0.9231M |
| June 30, 2020 | 2.385M |
| March 31, 2020 | 0.5015M |
| December 31, 2019 | 0.4893M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.4893M
Minimum
Dec 2019
5.304M
Maximum
Jun 2022
2.255M
Average
2.385M
Median
Jun 2020
Total Liabilities (Quarterly) Benchmarks
| Eyenovia Inc | 19.78M |
| Cassava Sciences Inc | 14.20M |
| Alpine Immune Sciences Inc | 51.91M |
| Clearside Biomedical Inc | 49.93M |
| Poseida Therapeutics Inc | 170.18M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 43.65M |
| Shareholders Equity (Quarterly) | 40.91M |